MaxCyte, Inc. (MXCT)
Makes machines that use electricity to engineer cells for drug development and manufacturing
$1.05+0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-48.5%
The outlook
MXCT trades at $1.05, near its 52-week low and well below both its 50- and 200-day moving averages. Analysts offer a Strong Buy consensus with an average price target about 291% above the current level, though coverage is limited to four analysts. The stock's positioning at the lower end of its yearly range reflects recent weakness despite the bullish analyst view.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 4 analysts
Price trendBelow its 50- & 200-day averages
52-week range25% of the way from its 52-week low to high
Price targetAvg target +291% vs current price
Analyst price target
~12-month · 4 analysts$4.11average target+291.2% vs now
Now $1.05
Low $2.43High $5.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$112.5M
52-wk high
$2.28
52-wk low
$0.64
50-day avg
$1.18
200-day avg
$1.18
Trailing P/E
—